Nearly 4,000 bottles of blood pressure medication have been pulled from shelves nationwide after failing federal quality standards, creating urgent concerns for American families relying on these prescriptions to manage their health.
FDA Orders Nationwide Pull After Test Failure
Macleods Pharma USA initiated the recall on October 7 for 3,528 bottles containing 30 pills and 216 bottles containing 90 pills of blood pressure medication. The Food and Drug Administration classified the recall on October 26 after the pills failed dissolution specifications, meaning they did not break down properly during required testing. Both affected lots expire on May 31, 2027, and remain in active recall status across the country.
The FDA designated this a Class II recall, indicating that using the affected medication could cause temporary or medically reversible health problems. While the agency considers the likelihood of serious health consequences remote, Americans taking these prescriptions should examine their medicine cabinets immediately to protect themselves and their families from potentially ineffective treatment.
Second Major Recall Hits Blood Pressure Market
This recall arrives just weeks after India-based Inventia Healthcare pulled 13,567 bottles of chlorthalidone tablets from American stores in September. That medication, used to treat high blood pressure and fluid retention, also failed dissolution testing according to Mayo Clinic records. The back-to-back failures raise questions about quality control standards for medications manufactured overseas and distributed to American consumers who depend on these drugs for critical health management.
What Americans Need to Know
Patients taking blood pressure medication should check their prescription bottles against the recalled lot numbers 12251163A and 12251163B. When pills fail dissolution testing, they may not release their active ingredients properly in the body, potentially leaving dangerous high blood pressure untreated despite regular medication use. Americans concerned about their prescriptions should contact their physicians immediately to discuss alternative medications and ensure their blood pressure remains under control. The ongoing nature of this recall demonstrates the continuing risks in pharmaceutical supply chains affecting everyday families across the nation. Macleods Pharma USA has not responded to requests for comment on the recall or quality control failures.